Target intelligence / Profile preview

Bacteriophage (Phage)

Target
Phage
Molecular classification
Virus, Biological agent, Antibacterial agent
01

Overview

Bacteriophages, or phages, are viruses that specifically infect and replicate within bacterial hosts [1]. They are the most abundant biological entities on Earth and play a fundamental role in maintaining microbial balance in various environments, including the human body [2]. In clinical applications, lytic phages are utilized as therapeutic agents—a practice known as phage therapy—to combat bacterial infections, particularly those caused by multi-drug resistant (MDR) pathogens [1, 4]. The therapeutic process involves the phage recognizing specific receptors on the bacterial cell surface, injecting its genetic material, and hijacking the host's machinery to produce new virions [3]. This process ultimately leads to the enzymatic lysis and death of the bacterium, releasing new phages to infect adjacent cells [3]. Unlike traditional antibiotics, phages are highly specific to their target bacterial species or strains, which helps preserve the host's commensal microbiome [1]. However, their use faces challenges such as the potential for rapid bacterial resistance and the release of pro-inflammatory endotoxins during bacterial lysis [3, 4]. Additionally, the narrow host range of phages often necessitates the development of personalized phage cocktails to match the specific infecting strain [4]. Despite these challenges, phages represent a promising alternative or adjunct to conventional antibiotics in the face of rising antimicrobial resistance [1].

Other names
PhageBacterial virusProkaryotic virus
02

Mechanism of action

Lytic cycle: adsorption to bacterial surface receptors, injection of viral DNA/RNA, replication of viral components, and enzymatic lysis of the bacterial cell wall via endolysins and holins [1, 3].

03

Biological functions

Bacterial lysisHorizontal gene transferMicrobiome regulationViral replication
04

Disease associations

Bacterial infectionAntimicrobial resistance (AMR)Cystic fibrosisSepsis
05

Safety considerations

Immunogenicity and anti-phage antibody productionRelease of bacterial endotoxins (LPS) during rapid lysisPotential for horizontal gene transfer of virulence factorsNarrow host range requiring precise strain matching
06

Interacting drugs

AB-SA01

4 more in the full profile.

07

Biomarkers

Phage susceptibility testing (PST)Bacterial host rangePlaque-forming units (PFU)

Beyond the preview

Go deeper on Bacteriophage (Phage).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacteriophage (Phage).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call